NCT01970306View on ClinicalTrials.gov

Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 18, 2013

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
Esophageal Adenocarcinoma
Interventions
DEVICE

MatriStem PSM

All esophageal anastomoses will be reinforced circumferentially with ACell MatriStem PSM.

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering West Harrison, Harrison

77030

Md Anderson Cancer Center, Houston

Unknown

Memorial Sloan Kettering Cancer Center, Basking Ridge

Sponsors
All Listed Sponsors
collaborator

Integra LifeSciences Corporation

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01970306 - Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material | Biotech Hunter | Biotech Hunter